Journal article
In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.
Abstract
SOURCE CITATION: WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499-518. 34228774.
Authors
Lo CKL; Chagla Z
Journal
Annals of Internal Medicine, Vol. 174, No. 11,
Publisher
American College of Physicians
Publication Date
November 2021
DOI
10.7326/acpj202111160-125
ISSN
1056-8751